Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Aug 27, 2023; 15(8): 1574-1590
Published online Aug 27, 2023. doi: 10.4240/wjgs.v15.i8.1574
Published online Aug 27, 2023. doi: 10.4240/wjgs.v15.i8.1574
Ref. | Number of patients (vascular complications/total CP patients) | Vascular complications | Risk factors |
Udd et al[81], 2007 | 33/745 (4.4%) | PsA: 33 (4.4%) | - |
Agarwal et al[20], 2008 | 34/157 (21.6%) | Splenic vein thrombosis: 34 (21.6%) | Pseudocyst (OR = 4.01) |
Pandey et al[23], 2019 | 37/187 (19.7%) | Splenic vein thrombosis: 37 (19.7%) | Smoking (OR = 3.021). Pseudocyst (OR = 3.743) |
Anand et al[21], 2020 | 166/1363 (12.2%) | Venous thrombosis: 132 (9.6%). PsA: 17/166 (1.24%). Both: 17 (1.24%) | Venous thrombosis: Alcohol (OR = 2.1); pseudocyst (OR = 4.6); inflammatory head mass (OR = 3.1). Pseudoaneurysms: Alcohol (OR = 3.49); pseudocyst (OR = 3.2) |
Ru et al[22], 2020 | 89/3358 (2.6%) | Splenic vein thrombosis: 89 (2.6%) | Alcohol (OR = 1.28). History of AP (OR = 2.56). Diabetes mellitus (OR = 3.82). Pseudocyst (OR = 8.54) |
Vujasinovic et al[17], 2021 | 33/394 (8.37%) | Venous thrombosis: 30 (7.6%). PsA: 3 (0.8%) | Alcohol (HR = 3.56). Pseudocyst (HR = 8.66) |
- Citation: Walia D, Saraya A, Gunjan D. Vascular complications of chronic pancreatitis and its management. World J Gastrointest Surg 2023; 15(8): 1574-1590
- URL: https://www.wjgnet.com/1948-9366/full/v15/i8/1574.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i8.1574